new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Merz Pharma Gmbh x26 Co Kgaa
Merz Pharma Gmbh x26 Co Kgaa_20131212
  

Merz Pharma Gmbh & Co Kgaa patents

Recent patent applications related to Merz Pharma Gmbh & Co Kgaa. Merz Pharma Gmbh & Co Kgaa is listed as an Agent/Assignee. Note: Merz Pharma Gmbh & Co Kgaa may have other listings under different names/spellings. We're not affiliated with Merz Pharma Gmbh & Co Kgaa, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Merz Pharma Gmbh & Co Kgaa-related inventors




Date Merz Pharma Gmbh & Co Kgaa patents (updated weekly) - BOOKMARK this page
05/04/17Novel uses of recombinant clostridial neurotoxins with decreased duration of effect
04/27/17Novel uses of recombinant clostridial neurotoxins with decreased duration of effect
03/16/17Neurotoxins exhibiting shortened biological activity
03/02/17Recombinant clostridial neurotoxins with increased duration of effect
03/02/17Gangliosides for standardizing and increasing the sensitivity of cells to botulinum neurotoxins in in vitro test systems
02/09/17Composition for improving the appearance of ageing skin
02/02/171-aminocyclohexane derivatives for the treatment of cochlear tinnitus
11/24/16Means and methods for manufacturing highly pure neurotoxin
10/06/16Means and methods for determination of botulinum neurotoxin biological activity
07/14/16Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells
06/30/16Formulation for stabilizing proteins, which is free of mammalian excipient
06/23/16Process for preparing a highly pure neurotoxic component of a botulinum toxin and uses thereof
05/19/16Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
03/17/16Therapeutic composition with a botulinum neurotoxin
03/10/16Method for the manufacturing of di-chain proteins for use in humans
02/04/16Neurotoxins exhibiting shortened biological activity
12/31/15Patch comprising an onion extract
11/26/15Filler composition comprising beta-glucans
11/12/15Recombinant clostridial neurotoxins with enhanced membrane localization
10/15/15High frequency application of botulinum toxin therapy
10/08/15Method for the determination of botulinum neurotoxin biological activity
09/24/15Cellular test systems for the determination of the biological activities of neurotoxin polypeptides
08/20/15Therapeutic composition with a botulinum neurotoxin
08/20/15Method of preparing a composition based on hyaluronic acid
08/20/15Method for the manufacturing of recombinant proteins harbouring an n-terminal lysine
06/18/15Pegylated mutated clostridium botulinum toxin
03/12/15Topical application of vinca alkaloids for the treatment of actinic keratosis
02/12/15Means and methods for determining neurotoxin activity based on a modified luciferase
01/15/15Titration package for neramexane and its use in the treatment of an inner ear disorder
01/08/15Filler comprising beads
12/25/14Method for the manufacturing of di-chain proteins for use in humans
12/25/14Chitosan beads and filler comprising such beads
12/18/14Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
10/09/14Use of adamantane derivatives for the treatment of actinic keratosis
09/04/14Composition comprising an onion extract and liposomes
08/14/141-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases
07/03/14Clostridial neurotoxins with altered persistency
06/26/14In situ formation of a filler
05/15/14Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities
04/17/14Therapeutic composition with a botulinum neurotoxin
04/17/141-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
02/13/14Neurotoxins exhibiting shortened biological activity
01/09/14High frequency application of botulinum toxin therapy
01/02/14Method for the determination of botulinum neurotoxin biological activity
12/12/13Composition comprising peroxisome proliferator-activated receptor-gamma
11/07/13Neramexane for the treatment or prevention of tinnitus related with stress or acute hearing loss
10/31/13Indole derivatives and process for their preparation
08/29/13Formulation suitable for stabilizing proteins, which is free of mammalian excipients
08/29/13Dipeptide analogs for treating conditions associated with amyloid fibril formation
08/01/13Filler composition comprising beta-glucans
08/01/13Pharmaceutical composition containing a tryptophan derivative
06/27/13Gel formulations for the topical use of 1-amino-alkylcyclohexane derivatives
06/20/13Pegylated mutated clostridium botulinum toxin
06/20/131-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
06/20/13Selective manufacture of recombinant neurotoxin polypeptides
06/13/131-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases
06/06/13Neramexane multiple unit dosage form
06/06/13Use of a cationic amphiphilic drug for the preparation of a formulation for the reduction of subcutaneous adipose tissue
05/16/13Therapeutic composition with a botulinum neurotoxin
05/16/13Method of preparing 3,3,5,5-tetramethylcyclohexanone
04/11/13Chitosan beads and filler comprising such beads
04/11/13Filler comprising beads
01/24/13In vitro assay for quantifying clostridial neurotoxin activity
09/20/12Compositions comprising cyclohexylamines and aminoadamantanes
08/30/12Glycine b antagonists
Patent Packs
08/23/12System for determining unprocessed and partially processed neurotoxin type a
07/26/12Eltoprazine for the treatment of weight disorders
07/12/12Metabotropic glutamate receptor modulators
05/31/12Eltoprazine for the treatment of anxiety
05/24/12Method of preparing neramexane
05/17/12Method of preparing 1-hydroxy-1,3,3,5,5-pentamethylcyclohexane
05/10/12Method of preparing neramexane
05/03/12Neurotoxins exhibiting shortened biological activity
04/26/12Liquid or pourable proteosome-forming bath and shower concentrates, galenic application products thereof, and their use
04/19/12Formulation for stabilizing proteins, which is free of mammalian excipient
04/12/12Therapeutic composition comprising a botulinum neurotoxin
01/05/12Means and methods for manufacturing highly pure neurotoxin
12/01/11Neramexane for the treatment or prevention of inner ear disorders
11/24/11Eltoprazine for the treatment of l-dopa-induced dyskinesia
11/24/11Method for producing memantine
Patent Packs
11/17/11Process for preparing memantine
10/27/11Process for manufacturing adamantane dervatives with high yield
10/13/11Compositions containing a capillary-active system with application-relevant diffferentiability and their use
10/13/111-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
10/13/11Halo active aromatic sulfonamide organic compounds and uses therefor
09/08/11Therapeutic composition comprising a botulinum neurotoxin
09/01/11Pyrazolopyrimidines for treating cns disorders
08/18/11Liposomal structures forming isometric agglomerates, especially bath beads, the production and use thereof
08/04/11Clostridial neurotoxins with altered persistency
07/21/111-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus
04/21/11Therapeutic composition with a botulinum neurotoxin
04/14/11Interval therapy for the treatment of tinnitus
03/31/111-aminocyclohexane derivatives for the treatment of cochlear tinnitus.
02/17/11Titration package
02/10/11Compartment-specific plant extract combination of ginkgo biloba extract and ginseng extract having a tandem effect
01/06/11Pyrazolopyrimidines, a process for their preparation and their use as medicine
12/30/10Use of a neurotoxic component of a clostridium botulinum toxin complex to reduce or prevent side effects.
11/25/10Titration package for neramexane and its use in the treatment of an inner ear disorder
11/25/101-amino-alkyl-cyclohexanes as 5-ht3 and neuronal nicotinic receptor antagonists
11/25/101-aminocyclohexane derivatives for the treatment of hearing loss
09/30/10Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue
09/16/10Neramexane for the treatment of nystagmus
09/09/10Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
08/05/101-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases
07/29/10Novel combination of neramexane for treatment of nerordegeneratie disorders
04/22/10Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases
03/25/10Combination of an nmda receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
02/11/10Compositions comprising cyclohexylamines and aminoadamantanes
12/03/09Method for producing 1-formamido-3,5-dimethyladamantane
09/10/09Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
Social Network Patent Pack
07/02/09Compositions containing proteins for the transfer/recycling of structurally modified lipids, and the applications thereof
05/14/09Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase and inhibitors
03/26/091-aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
12/12/13Composition comprising peroxisome proliferator-activated receptor-gamma







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Merz Pharma Gmbh & Co Kgaa in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Merz Pharma Gmbh & Co Kgaa with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';